Chronobiology Impacts Response to Antihypertensive Drug Regimen in Type 2 Diabetes

Por Friedman, Eli A., Banerji, Mary Ann
Publicado em 2011

Impact of Glycemic Control on Healthcare Resource Utilization and Costs of Type 2 Diabetes: Current and Future Pharmacologic Approaches to Improving Outcomes

Por Banerji, Mary Ann, Dunn, Jeffrey D.
Publicado em 2013

Glucagon-Like Peptide-1 as Predictor of Body Mass Index and Dentate Gyrus Neurogenesis: Neuroplasticity and the Metabolic Milieu

Por Coplan, Jeremy D., Syed, Shariful, Perera, Tarique D., Fulton, Sasha L., Banerji, Mary Ann, Dwork, Andrew J., Kral, John G.
Publicado no Neural Plast (2014)

Diabetic Retinopathy, Its Progression, and Incident Cardiovascular Events in the ACCORD Trial

Por Gerstein, Hertzel C., Ambrosius, Walter T., Danis, Ronald, Ismail-Beigi, Faramarz, Cushman, William, Calles, Jorge, Banerji, MaryAnn, Schubart, Ulrich, Chew, Emily Y.
Publicado em 2013

Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial

Por Chen, Lin Y., Bigger, J. Thomas, Hickey, Kathleen T., Chen, Haiying, Lopez-Jimenez, Carlos, Banerji, Mary Ann, Evans, Gregory, Fleg, Jerome L., Papademetriou, Vasilios, Thomas, Abraham, Woo, Vincent, Seaquist, Elizabeth R., Soliman, Elsayed Z.
Publicado no Am J Hypertens (2016)

Effect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup Characteristics: The Action to Control Cardiovascular Risk in Diabetes (A...

Por Calles-Escandón, Jorge, Lovato, Laura C., Simons-Morton, Denise G., Kendall, David M., Pop-Busui, Rodica, Cohen, Robert M., Bonds, Denise E., Fonseca, Vivian A., Ismail-Beigi, Faramarz, Banerji, Mary Ann, Failor, Alan, Hamilton, Bruce
Publicado em 2010

Actos Now for the prevention of diabetes (ACT NOW) study

Por DeFronzo, Ralph A, Banerji, MaryAnn, Bray, George A, Buchanan, Thomas A, Clement, Stephen, Henry, Robert R, Kitabchi, Abbas E, Mudaliar, Sunder, Musi, Nicolas, Ratner, Robert, Reaven, Peter D, Schwenke, Dawn, Stentz, Frankie B, Tripathy, Devjit
Publicado em 2009

METABOLIC SYNDROME AND NEUROMETABOLIC ASYMMETRY OF HIPPOCAMPUS IN ADULT BONNET MONKEYS

Por Coplan, Jeremy D., Abdallah, Chadi G., Mathew, Sanjay J., Shungu, Dikoma C., Mao, Xiangling, Smith, Eric L.P., Kaufman, Daniel, Gorman, Jack M., Owens, Michael J., Nemeroff, Charles B., Banerji, Mary Ann, Rosenblum, Leonard A., Kral, John G.
Publicado em 2011

Prevention of Diabetes With Pioglitazone in ACT NOW: Physiologic Correlates

Por DeFronzo, Ralph A., Tripathy, Devjit, Schwenke, Dawn C., Banerji, MaryAnn, Bray, George A., Buchanan, Thomas A., Clement, Stephen C., Gastaldelli, Amalia, Henry, Robert R., Kitabchi, Abbas E., Mudaliar, Sunder, Ratner, Robert E., Stentz, Frankie B., Musi, Nicolas, Reaven, Peter D.
Publicado em 2013

Prediction of Diabetes Based on Baseline Metabolic Characteristics in Individuals at High Risk

Por DeFronzo, Ralph A., Tripathy, Devjit, Schwenke, Dawn C., Banerji, MaryAnn, Bray, George A., Buchanan, Thomas A., Clement, Stephen C., Henry, Robert R., Kitabchi, Abbas E., Mudaliar, Sunder, Ratner, Robert E., Stentz, Frankie B., Musi, Nicolas, Reaven, Peter D., Gastaldelli, Amalia
Publicado em 2013

Baseline Adiponectin Levels Do Not Influence the Response to Pioglitazone in ACT NOW

Por Tripathy, Devjit, Clement, Stephen C., Schwenke, Dawn C., Banerji, MaryAnn, Bray, George A., Buchanan, Thomas A., Gastaldelli, Amalia, Henry, Robert R., Kitabchi, Abbas E., Mudaliar, Sunder, Ratner, Robert E., Stentz, Frankie B., Musi, Nicolas, Reaven, Peter D., DeFronzo, Ralph A.
Publicado em 2014

Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance

Por Espinoza, Sara E., Wang, Chen-pin, Tripathy, Devjit, Clement, Stephen C., Schwenke, Dawn C., Banerji, Mary Ann, Bray, George A., Buchanan, Thomas A., Henry, Robert R., Kitabchi, Abbas E., Mudaliar, Sunder, Stentz, Frankie B., Reaven, Peter D., DeFronzo, Ralph A., Musi, Nicolas
Publicado no Age (Dordr) (2016)

Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors

Por Saremi, Aramesh, Schwenke, Dawn C., Buchanan, Thomas A., Hodis, Howard N., Mack, Wendy J., Banerji, MaryAnn, Bray, George A., Clement, Stephen C., Henry, Robert R., Kitabchi, Abbas E., Mudaliar, Sunder, Ratner, Robert E., Stentz, Frankie B., Musi, Nicolas, Tripathy, Devjit, DeFronzo, Ralph A., Reaven, Peter D.
Publicado em 2012

Effects of TZD Use and Discontinuation on Fracture Rates in ACCORD Bone Study

Por Schwartz, Ann V., Chen, Haiying, Ambrosius, Walter T., Sood, Ajay, Josse, Robert G., Bonds, Denise E., Schnall, Adrian M., Vittinghoff, Eric, Bauer, Douglas C., Banerji, Mary Ann, Cohen, Robert M., Hamilton, Bruce P., Isakova, Tamara, Sellmeyer, Deborah E., Simmons, Debra L., Shibli-Rahhal, Amal, Williamson, Jeff D., Margolis, Karen L.
Publicado no J Clin Endocrinol Metab (2015)

Effect of intensive treatment of hyperglycemia on microvascular complications of type 2 diabetes in ACCORD: a randomized trial

Por Ismail-Beigi, Faramarz, Craven, Timothy, Banerji, MaryAnn, Basile, Jan, Calles, Jorge, Cohen, Robert, Cuddihy, Robert, Cushman, William C, Genuth, Saul, Grimm, Richard H, Hamilton, Bruce, Hoogwerf, Byron, Karl, Diane, Katz, Lois, Krikorian, Armand, O'Connor, Patrick, Pop-Busui, Rodica, Schubart, Ulrich, Simmons, Debra, Taylor, Harris, Thomas, Abraham, Weiss, Daniel, Hramiak, Irene
Publicado em 2010

A Novel Insulin Resistance Index to Monitor Changes in Insulin Sensitivity and Glucose Tolerance: the ACT NOW Study

Por Tripathy, Devjit, Cobb, Jeff E., Gall, Walter, Adam, Klaus-Peter, George, Tabitha, Schwenke, Dawn C., Banerji, MaryAnn, Bray, George A., Buchanan, Thomas A., Clement, Stephen C., Henry, Robert R., Kitabchi, Abbas E., Mudaliar, Sunder, Ratner, Robert E., Stentz, Frankie B., Reaven, Peter D., Musi, Nicolas, Ferrannini, Ele, DeFronzo, Ralph A.
Publicado no J Clin Endocrinol Metab (2015)